Omega-3 PUFA

Omega-3 PUFA

Global Omega-3 PUFA Market to Reach US$18.2 Billion by 2030

The global market for Omega-3 PUFA estimated at US$8.3 Billion in the year 2023, is expected to reach US$18.2 Billion by 2030, growing at a CAGR of 11.9% over the analysis period 2023-2030. Docosahexaenoic acid (DHA), one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$8.7 Billion by the end of the analysis period. Growth in the Eicosapentaenoic acid (EPA) segment is estimated at 14.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 15.3% CAGR

The Omega-3 PUFA market in the U.S. is estimated at US$2.2 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 15.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Global Omega-3 PUFA Market – Key Trends & Drivers Summarized

What Are Omega-3 PUFAs and Why Are They Important?

Omega-3 polyunsaturated fatty acids (PUFAs) are essential fats that play a critical role in human health, particularly in cardiovascular, brain, and immune system function. Commonly found in fish oils, flaxseed, and algae, the most important types of omega-3 PUFAs are eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA). These fatty acids are not synthesized by the body, making dietary intake or supplementation essential. Omega-3 PUFAs are widely recognized for their anti-inflammatory properties, which are beneficial in reducing the risk of heart disease, supporting cognitive health, and promoting overall wellness. As awareness of the health benefits of omega-3 continues to grow, so does the demand for omega-3 supplements, fortified foods, and other functional products.

How Are Technological Advancements Shaping the Omega-3 PUFA Market?

Technological advancements in omega-3 extraction and purification processes have significantly improved the quality and sustainability of omega-3 PUFA products. New extraction methods, such as supercritical fluid extraction, allow for the efficient production of high-purity omega-3 oils with minimal environmental impact. Additionally, the rise of plant-based and algal sources of omega-3 PUFAs is expanding the market, offering sustainable and vegan-friendly alternatives to traditional fish oil-based supplements. These advancements address concerns about overfishing and the environmental impact of marine-based omega-3 production. Furthermore, innovations in microencapsulation technology have enabled the incorporation of omega-3 PUFAs into a wide range of functional foods and beverages without affecting taste or stability, making it easier for consumers to integrate omega-3 into their daily diets.

Why Is Consumer Demand for Omega-3 PUFAs Rising Globally?

The growing awareness of the health benefits associated with omega-3 PUFAs has been a major driver of demand worldwide. Consumers are increasingly seeking supplements and functional foods that promote heart health, cognitive function, and joint health, particularly as aging populations become more health-conscious. Omega-3s are also widely recommended by healthcare professionals for managing conditions like high cholesterol, hypertension, and inflammation. The demand for omega-3 PUFAs is not limited to supplements; food and beverage companies are fortifying everyday products, such as milk, yogurt, and infant formulas, with these essential fatty acids. This trend aligns with the broader consumer shift towards preventive healthcare and nutritional solutions for long-term wellness. Additionally, athletes and fitness enthusiasts are driving demand for omega-3s due to their benefits in reducing exercise-induced inflammation and promoting recovery.

What Factors Are Driving the Growth of the Omega-3 PUFA Market?

The growth in the omega-3 PUFA market is driven by several factors, including rising consumer awareness of its health benefits, expanding applications in food and beverage products, and advancements in sustainable sourcing. The aging global population is a key driver, as omega-3 supplements are increasingly recommended for cardiovascular and cognitive health. Technological advancements in extraction methods, especially from algal sources, are addressing sustainability concerns and attracting vegan and vegetarian consumers. The increasing use of omega-3 PUFAs in fortified foods and beverages is expanding market penetration beyond supplements, with product innovation making it easier for consumers to incorporate omega-3 into their diets. Furthermore, the growing popularity of preventive healthcare and the increased focus on wellness have contributed to the rising demand for omega-3 products.

Select Competitors (Total 11 Featured) -
  • Arista Industries Inc.
  • Cargill, Inc.
  • Croda International PLC
  • FMC Corporation
  • Gc Rieber Oil
  • Omega Protein Corporation
  • Pharma Marine AS
  • Polaris
  • Royal DSM NV
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Omega-3 PUFA – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Consumer Awareness of the Health Benefits of Omega-3 PUFAs Drives Global Demand Across Nutraceuticals and Functional Foods Markets
Increasing Prevalence of Cardiovascular Diseases and Growing Focus on Heart Health Spur Consumption of Omega-3 Supplements Worldwide
Expansion of Plant-Based Omega-3 Sources, Such as Algal Oils, Strengthens the Business Case for Vegan and Vegetarian Supplements
Growing Application of Omega-3 PUFAs in Infant Nutrition Products Propels Market Growth Amid Rising Demand for High-Quality Ingredients
Rising Consumer Focus on Mental Health and Cognitive Function Drives Adoption of Omega-3 PUFAs in Brain Health Supplements
Technological Advancements in Microencapsulation and Delivery Systems Propel the Fortification of Omega-3s into Beverages and Functional Foods
Increasing Regulatory Approvals for Omega-3 Health Claims Expands Market Opportunities in Health Supplements and Food Products
Growing Popularity of Personalized Nutrition Strengthens Demand for Tailored Omega-3 Supplement Formulations
Increasing Application of Omega-3 PUFAs in Pet Nutrition Products Drives New Opportunities in the Animal Health Segment
Rising Consumer Awareness of Omega-3 Role in Joint and Inflammatory Health Generates Demand for Omega-3-Enriched Products
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Omega-3 PUFA Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Omega-3 PUFA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Docosahexaenoic acid (DHA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Docosahexaenoic acid (DHA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Docosahexaenoic acid (DHA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Eicosapentaenoic acid (EPA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Eicosapentaenoic acid (EPA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Eicosapentaenoic acid (EPA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Alpha linoleic acid (ALA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Alpha linoleic acid (ALA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Alpha linoleic acid (ALA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Marine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Marine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Marine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Plant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Plant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Plant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Dietary Supplements & Functional Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Infant Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Pet & Animal Feed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Pet & Animal Feed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Pet & Animal Feed by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
CHINA
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 62: China Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 71: Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Omega-3 PUFA by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
FRANCE
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 83: France Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 92: Germany Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 101: Italy Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 110: UK Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 113: UK Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
SPAIN
TABLE 119: Spain Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Spain Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Spain 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 122: Spain Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Spain 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 125: Spain Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Spain 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
RUSSIA
TABLE 128: Russia Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Russia Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Russia 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 131: Russia Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Russia 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 134: Russia Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Russia 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of Europe 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of Europe 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Omega-3 PUFA by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
AUSTRALIA
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 158: Australia Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Australia Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Australia 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 161: Australia Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Australia 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 164: Australia Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Australia 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
INDIA
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 167: India Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: India Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: India 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 170: India Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: India Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: India 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 173: India Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: India Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: India 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 176: South Korea Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: South Korea Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: South Korea 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 179: South Korea Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: South Korea 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 182: South Korea Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: South Korea 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Asia-Pacific Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
LATIN AMERICA
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 194: Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Omega-3 PUFA by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 197: Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Latin America 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Latin America 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 206: Argentina Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Argentina Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Argentina 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 209: Argentina Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Argentina 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 212: Argentina Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Argentina 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
BRAZIL
TABLE 215: Brazil Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Brazil Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Brazil 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 218: Brazil Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Brazil 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 221: Brazil Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Brazil 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
MEXICO
TABLE 224: Mexico Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Mexico Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Mexico 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 227: Mexico Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 229: Mexico 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 230: Mexico Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 232: Mexico 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 234: Rest of Latin America Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 235: Rest of Latin America 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 238: Rest of Latin America 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 241: Rest of Latin America 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
MIDDLE EAST
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 242: Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Omega-3 PUFA by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 245: Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 250: Middle East 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 253: Middle East 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
IRAN
TABLE 254: Iran Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 255: Iran Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 256: Iran 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 257: Iran Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 259: Iran 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 260: Iran Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 262: Iran 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
ISRAEL
TABLE 263: Israel Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 264: Israel Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 265: Israel 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 266: Israel Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 268: Israel 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 269: Israel Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 271: Israel 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 273: Saudi Arabia Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 274: Saudi Arabia 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 277: Saudi Arabia 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 280: Saudi Arabia 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 281: UAE Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 282: UAE Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 283: UAE 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 284: UAE Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 286: UAE 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 287: UAE Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 289: UAE 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 291: Rest of Middle East Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 292: Rest of Middle East 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 295: Rest of Middle East 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 298: Rest of Middle East 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
AFRICA
Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 299: Africa Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 300: Africa Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 301: Africa 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
TABLE 302: Africa Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 304: Africa 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
TABLE 305: Africa Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 307: Africa 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings